Dolutegravir/lamivudine FDC recommended by NHS England
Simon Collins, HIV i-Base
On 12 March 2020 the specialised commissioning document for dolutegravir/lamivudine was published.
The was after what is alwasy a long protracted process, even with the best intentions for faster access.
Doctors should now be able to prescriber this single-pill formulation, in line with prescribing guidelines.
NHS England. Dolutegravir / lamivudine for the treatment of Human Immunodeficiency Virus (HIV-1) infected adults and adolescents over 12 years of age